Trademark: 79336645
Word
CENTOMETABOLOME
Status
Registered
Status Code
700
Status Date
Tuesday, June 13, 2023
Serial Number
79336645
Registration Number
7077610
Registration Date
Tuesday, June 13, 2023
Mark Type
4000
Filing Date
Monday, November 8, 2021
Published for Opposition
Tuesday, March 28, 2023

Trademark Owner History
Centogene GmbH - Original Registrant

Classifications
5 Diagnostic preparations for medical and veterinary purposes; diagnostic biomarker reagents for medical or veterinary purposes; preparations for detecting genetic predispositions for medical or veterinary purposes; reagents for medical use for determining a metabolome, in particular a metabolome in the event of a disease; nucleic acid sequences for medical and veterinary purposes; metabolites for medical use and for veterinary purposes in the nature of lipids, amino acids, and steroids
35 Collating and systematic ordering of data in a computer database, namely, systemization of data into computer databases; computerized file management; data search in computer files for others, namely, searching and reviewing data pulled from the computer files of others and annotating such data on behalf of others for business purposes; compilation of statistical data relating to medical research for business purposes; compilation of statistical data for use in scientific research for business purposes
44 Conducting of medical tests for diagnostic or treatment purposes; medical testing to determine the metabolome in an organism; medical testing for supporting the methods of diagnostic and treatment purposes to determine the metabolome in an organism; medical services in the fields of DNA sequencing for diagnostic purposes, genetic science, genetic testing, and metabolomics; medical analysis in connection with the treatment of individuals in relation to metabolism and metabolomics; medical analysis services for research purposes provided by medical laboratories for the analysis of samples taken from patients; providing of information in the fields of medicine and veterinary medicine; provision of information, in relation to metabolism and metabolomics; medical information
42 Scientific and technological services, namely quality control of the metabolic measurement, univariate and multivariate statistical analysis for feature extraction, discovery of metabolic biomarkers, training of supervised machine learning models on metabolic data, annotation of spectral features with chemical structures, stratification of samples based on pathologic genetic variants, gender, sample origin, patient age, medication; industrial analysis and research services in the field of biotechnology, namely, discovery of biomarker and stratification of samples based on pathologic genetic variants, gender, sample origin, patient age, medication; research and development services, in relation to biotechnology, pharmacology, metabolomics; genetic engineering services; research and development in the field of medical diagnostics; design, development, programming and implementation of software and computerized databases; computerised scientific research, testing and analysis; design and development of computer hardware; software as a service featuring software for quality control of the metabolic measurement, univariate and multivariate statistical analysis for feature extraction, discovery of metabolic biomarkers, training of supervised machine learning models on metabolic data, annotation of spectral features with chemical structures, stratification of samples based on pathologic genetic variants, gender, sample origin, patient age, medication; rental of computer software for data processing; software as a service (SaaS) featuring software for quality control of the metabolic measurement, univariate and multivariate statistical analysis for feature extraction, discovery of metabolic biomarkers, training of supervised machine learning models on metabolic data, annotation of spectral features with chemical structures, stratification of samples based on pathologic genetic variants, gender, sample origin, patient age, medication in the field of metabolome; provision of information, in relation to pharmacology, metabolomics

Trademark Events
Oct 10, 2023
Final Decision Transaction Processed By Ib
Sep 15, 2023
Final Disposition Notice Sent To Ib
Sep 15, 2023
Final Disposition Processed
Sep 13, 2023
Final Disposition Notice Created, To Be Sent To Ib
Jun 13, 2023
Notice Of Registration Confirmation Emailed
Jun 13, 2023
Registered-Principal Register
Mar 28, 2023
Official Gazette Publication Confirmation E-Mailed
Mar 28, 2023
Published For Opposition
Mar 8, 2023
Notification Of Notice Of Publication E-Mailed
Feb 22, 2023
Approved For Pub - Principal Register
Feb 16, 2023
Teas/Email Correspondence Entered
Feb 16, 2023
Correspondence Received In Law Office
Feb 16, 2023
Teas Response To Office Action Received
Sep 12, 2022
Refusal Processed By Ib
Aug 20, 2022
Non-Final Action Mailed - Refusal Sent To Ib
Aug 20, 2022
Refusal Processed By Mpu
Jul 27, 2022
Non-Final Action (Ib Refusal) Prepared For Review
Jul 26, 2022
Non-Final Action Written
Jul 20, 2022
Assigned To Examiner
Mar 29, 2022
Application Filing Receipt Mailed
Mar 25, 2022
New Application Office Supplied Data Entered
Mar 24, 2022
Sn Assigned For Sect 66a Appl From Ib

Trademark Alertz updated from USPTO on 2030-01-24